A Diverse and Constantly Improving Range of Quality Pharmaceutical Products.
In accordance with the needs of patients and the global pharmaceutical market, Hemofarm’s rich product range comprises prescription drugs (Rx), Over-the-counter medicines (OTC) and Consumer Healthcare products (CHC products) the majority of which are dietary supplements.

Monitoring risk factors, the most common causes of mortality, as well as the trend in Serbia, Hemofarm is committed to continuously meeting the needs of the population in the most suitable preventive and/or therapeutic way, thus preventing the occurrence of health problems as well as alleviating the symptoms of deteriorated health.
1 CV - Heart and blood vessel diseases are the leading cause of death in Serbia. One of the main health problems is acute coronary syndrome which inludes myocardial infraction and unstable angina pectoris.
2 CNS- The number of personas suffering from depression is increasing in Serbia. Doctors predict that depression will be the second most common disease in Serbia.
3 Infectious diseases- Development of antibiotics represents one of the greatest achievements of the 20th century which has extended life-expectancy.
4 Metabolism- In Sebia, 8.6 % of people suffer from diabetes, taking into account that there is one person with diabetes type 1 in 10 people with diabetes type 2.
5 Musculoskeletal system- Rheumatic disease has 150 subtypes but most people suffer from rheumatoid arthritis and osteoarthritis.
6 Respiratory system- Each third man and each fourth woman are smokers in Serbia, as well as each third pregnat woman and each seventh adolescent.
7 Global burden of diseases, injuries, and risk factors study 2010, Institute for Health Metrics and Evaluation,
S. Janković et al, The burden of disease and injurz in Serbia, Eur J Public Health, Vol. 17, No. 1, 80-85
Permanently monitoring consumer needs and predicting market trends, Hemofarm regularly and continuously optimizes its product range through the launch of new generations of products, with improved performances/characteristics and in line with contemporary global therapeutic protocols and therapeutic trends.
Hemofarm constantly optimizes and develops its product range, covering the following pharmacotherapeutic groups:
  • Alimentary tract and metabolism
  • Blood and blood forming organs
  • Cardiovascular system
  • Dermatologicals medicines
  • Genito-urinary system and sex hormones
  • Systemic hormonal preparations, excluding sex hormones
  • Antiinfectives for systemic use
  • Musculo-skeletal system
  • Central Nervous System
  • Respiratory system
  • Sensory organs
  • Antineoplastics and immunomodulators